QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Chai, L. Articles by Rönnekleiv, O. K. Search for Related Content PubMed PubMed Citation Articles by Chai, L. Articles by Rönnekleiv, O. K.

 Previous Article  |  Next Article 

Volume 17, Number 3, Issue of February 1, 1997 pp. 1112-1121
Copyright ©1997 Society for Neuroscience

Maternal Cocaine Treatment Alters Dynorphin and Enkephalin mRNA Expression in Brains of Fetal Rhesus Macaques

Received Aug. 26, 1996; revised Nov. 21, 1996; accepted Nov. 25, 1996.

Lin Chai, Wan S. Choi, and Oline K. Rönnekleiv

Department of Physiology and Pharmacology, Oregon Health Sciences University, Portland, Oregon 97201, and Division of Neuroscience, Oregon Regional Primate Research Center, Beaverton, Oregon 97006

Cocaine exposure in utero is known to cause a variety of behavioral and motor deficits that may be attributable to alterations in the dopamine neurocircuitry. To ascertain cocaine effects in the fetus, we developed a nonhuman primate model in which pregnant monkeys were administered cocaine from day 20 through day 60 or 70 of gestation. Fetuses from these pregnancies develop a repertoire of neural deficiencies, including decreased mRNA expression of tyrosine hydroxylase in the midbrain and increased mRNA expression of dopamine receptor subtypes in the rostral forebrain. Presently, we studied the effects of maternal cocaine treatment on the mRNA expression of the endogenous opioids preprodynorphin (PPD) and preproenkephalin (PPE) in fetal monkey brains. Fetuses exposed to saline (0.9%) or cocaine (3 mg/kg) were delivered by Caesarean section, the fetal brains were dissected, and tissue RNA was extracted and quantified using ribonuclease protection assay analysis. The opioid peptides PPD and PPE were expressed in the fetal monkey brain by day 60, and even higher levels were found in day 70 fetuses. Maternal exposure to cocaine increased gene expression of PPD and PPE in the fetus at both day 60 and day 70 of gestation. Dynorphin mRNA levels were significantly elevated in the striatum, whereas enkephalin mRNA was elevated in both the frontal cortex and the striatal area of fetuses whose mothers received cocaine. Changes in the expression of these opioid peptides in presumed dopamine target neurons, which mediate motivation and reward, as well as motor control, provide further evidence for profound consequences of in utero cocaine exposure on the developing dopamine neurocircuitry.

Key words: fetal monkey; development; cocaine; enkephalin mRNA; dynorphin mRNA; frontal cortex; striatal area

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help